MagDI Canada Study

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2027

Conditions
ObesityType 2 Diabetes
Interventions
DEVICE

Magnet System, DI Biofragmentable

Anastomoses achieved by magnetic compression.

Trial Locations (3)

Unknown

NOT_YET_RECRUITING

University of Toronto, Toronto

H3A 0G4

NOT_YET_RECRUITING

McGill University, Montreal

H3Z 2P9

RECRUITING

Westmount Square Surgical Center, Westmount

Sponsors
All Listed Sponsors
lead

GT Metabolic Solutions, Inc.

INDUSTRY

NCT06467955 - MagDI Canada Study | Biotech Hunter | Biotech Hunter